Baseline measure of health-related quality of life (Functional Assessment of Cancer Therapy-Esophagus) is associated with overall survival in patients with esophageal cancer Read at the 95th Annual Meeting of the American Association for Thoracic Surgery, Seattle, Washington, April 25-29, 2015.

Journal of Thoracic and Cardiovascular Surgery

Volumn 151, Issue 6, 2016, Pages 1571-1580

  Kidane, Biniam ^a   Sulman, Joanne ^a,b   Xu, Wei ^d   Kong, Qin Quinn ^d   Wong, Rebecca ^c,d   Knox, Jennifer J ^b,d   Darling, Gail E ^a,d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

esophageal cancer; predictive model; quality of life; survival

Indexed keywords

SUNITINIB;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FOLLOW UP; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ESOPHAGUS; GASTROESOPHAGEAL JUNCTION; HEAD AND NECK SURGERY; HUMAN; LEFT NECK INCISION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; ADENOCARCINOMA; AGED; CANCER STAGING; ESOPHAGEAL NEOPLASMS; FEMALE; HEALTH STATUS INDICATOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL;

ADENOCARCINOMA; ADULT; AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE;

EID: 84962590885     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2016.01.052     Document Type: Article

References (15)

1. G.E. Darling Quality of life in patients with esophageal cancer Thorac Surg Clin 23 2013 569 575
2. N. Safieddine, W. Xu, S.M. Quadri, J.J. Knox, J. Hornby, J. Sulman, and et al. Health-related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention J Thorac Cardiovasc Surg 137 2009 36 42
3. C.C. Gotay, C.T. Kawamoto, A. Bottomley, and F. Efficace The prognostic significance of patient-reported outcomes in cancer clinical trials J Clin Oncol 26 2008 1355 1363
4. N.R. Maisey, A. Norman, M. Watson, M.J. Allen, M.E. Hill, and D. Cunningham Baseline quality of life predicts survival in patients with advanced colorectal cancer Eur J Cancer 38 2002 1351 1357
5. T. Djarv, and P. Lagergren Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery Eur J Cancer 47 2011 530 535
6. T. Djarv, C. Metcalfe, K.N. Avery, P. Lagergren, and J.M. Blazeby Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer J Clin Oncol 28 2010 1666 1670
7. J.M. Blazeby, S.T. Brookes, and D. Alderson The prognostic value of quality of life scores during treatment for oesophageal cancer Gut 49 2001 227 230
8. J.J. Knox, R. Wong, A.L. Visbal, A.M. Horgan, M. Guindi, J. Hornby, and et al. Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer Cancer 116 2010 4023 4032
9. G. Darling, D.T. Eton, J. Sulman, A.G. Casson, and D. Celia Validation of the functional assessment of cancer therapy esophageal cancer subscale Cancer 107 2006 854 863
10. D.B. Mendel, A.D. Laird, X. Xin, S.G. Louie, J.G. Christensen, G. Li, and et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship Clin Cancer Res 9 2003 327 337
11. M. van Heijl, M.A. Sprangers, A.G. de Boer, S.M. Lagarde, H.B. Reitsma, O.R. Busch, and et al. Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer Ann Surg Oncol 17 2010 23 30
12. J.A. Brooks, K.A. Kesler, C.S. Johnson, D. Ciaccia, and J.W. Brown Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results J Surg Oncol 81 2002 185 194
13. J.M. Blazeby, T. Conroy, E. Hammerlid, P. Fayers, O. Sezer, M. Koller, and et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer Eur J Cancer 39 2003 1384 1394
14. A. Sharma, L.G. Walker, and J.R. Monson Baseline quality of life factors predict long term survival after elective resection for colorectal cancer Int J Surg Oncol 2013 2013 269510
15. C. Quinten, F. Martinelli, C. Coens, M.A. Sprangers, J. Ringash, C. Gotay, and et al. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites Cancer 120 2014 302 311